Monoclonal antibody αIR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 171 (3) , 1244-1251
- https://doi.org/10.1016/0006-291x(90)90819-9
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Studies with Insulin and Insulin-Like Growth Factor-I Show that the Increased Labeling of Phosphatidylinositol-3,4-Bisphosphate Is not Sufficient to Elicit the Diverse Actions of Epidermal Growth Factor on MA-10 Leydig Tumor CellsMolecular Endocrinology, 1990
- Monoclonal antibodies to phosphotyrosineJournal of Immunological Methods, 1988
- Structure of the Receptor for Insulin-Like Growth Factor II: The Puzzle AmplifiedScience, 1988
- Insulin‐like growth factor II binding and action in human fetal fibroblastsJournal of Cellular Physiology, 1987
- Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factorBiochemical and Biophysical Research Communications, 1986
- Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domainBiochemistry, 1986
- Interaction of the Monoclonal AntibodiesαlR-1 andαIR-3 with Insulin and Somatomedin-C ReceptorsEndocrinology, 1986
- Actions of Insulin-Like Growth FactorsAnnual Review of Physiology, 1985
- Characterization of monoclonal antibodies to the IGF-I receptor that inhibit IGF-I binding to human cellsBiochemical and Biophysical Research Communications, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970